Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Lucid Group acquires strategic brand consultants DiD

Acquisition will boost agency’s existing presence in the US

- PMLiVE

GCI Health announces expansion into the Middle East

GCI Health Middle East will be led by Kath Kerry, president – Europe & Middle East

S Marchant (L) A Korving (C) D Youds (R)

RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

Stephen Marchant has joined Resonant Group in the newly created role of Chief Development Officer.  He will be working with the Board to create, grow and acquire businesses and services to...

Origins – The Patient Focused Specialists

- PMLiVE

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks

Partnership will utilise real-world data for the early reporting of global outbreaks

Biogen Idec building

Biogen to begin shipping newly approved Alzheimer’s treatment in two weeks

Just days after the drug was approved by the FDA advisory panel, two of its members have resigned

- PMLiVE

US to donate 500 million Pfizer/BioNTech COVID-19 vaccine doses through COVAX

As part of the agreement, 500 million doses will be delivered between August 2021 and June 2022

- PMLiVE

The pursuit of patient diversity in clinical trials

When all-inclusive isn’t an option, it’s an obligation

Lucid Group acquires US-based strategic brand consultants DiD

Lucid Group has acquired the US-based strategic brand consultants, DiD. This union will strengthen Lucid Group’s existing presence in the US and its ability to provide a compelling strategic, creative...

Lucid Group Communications Limited

- PMLiVE

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.

Avalere Health

- PMLiVE

FDA lifts clinical hold on bluebird bio’s LentiGlobin studies

Company previously put trials on hold after suspected unexpected serious adverse reactions

Rediscovering the human touch in healthcare

The landscape of our healthcare system is ever evolving. But it is under threat from the diminishing time allowances our healthcare professionals have to spend with each patient. With little...

Page & Page Health

- PMLiVE

J&J exits $1.6bn blood cancer drug licensing deal with argenx

J&J and argenx signed a deal in 2018 to develop cusatuzumab to treat haematological cancers

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links